Operating Sales Margin: Zymeworks Inc (ZYME)

Corporate company logo of Zymeworks Biopharmaceuticals (ZYME)

Zymeworks Inc. (ZYME) does not pay dividends, focusing instead on the sterile delivery of biologics. The historical operating margin serves as a confidence indicator, with the latest value recorded as 16.60. Market capitalization growth relies on the multispecific antibody platform and the success of zanidatamab. The financial stability of Zymeworks Inc. (ZYME) is supported by partner advances, rendering the development cycle independent of external economic shocks.

ZYME: zymeworks.com Operating Profit Rate 07/04/2022 - 11/19/2026

Zymeworks Inc. - analytical breakdowns and key metrics (ZYME)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Basic company analysis:ZYME, Zymeworks
Core merchandise of Zymeworks Biopharmaceuticals

Operating margin measures the share of profit from core operations before accounting for debt obligations and taxes. This ratio demonstrates internal cost management efficiency and the actual profitability of the business model. By analyzing operating profitability, an investor can distinguish sustainable growth from temporary market fluctuations. For Zymeworks Inc. (ZYME), this metric confirms financial stability. Diversification of bioengineered protein suppliers minimizes logistical risks, supporting operational efficiency.

Who Zymeworks Inc. competes with

Operating Sales Margin IBRX|IMCR - Operating Profitability Margin|Operating Sales Margin JANX (Janux Pharma)|Operating Profit Ratio RCUS|Operating Margin TNGX (Tango Therapeutics, Inc.)|Operating Profit Rate IOVA|immatics.com - Operating Margin|Operating Return on Sales Xencor Inc.|Compass Therapeutics (CMPX) - Operating Profitability|Replimune Group, Inc. - Operating Profit Rate|LYEL (lyell.com) - Operating Margin|Operating Margin Innate Pharma SA|Operating Profitability pyxisoncology.com (PYXS)|CGEN: Operating Profit Margin|IO Biotech Inc - Operating Sales Margin|sutrobio.com (STRO) - Operating Return on Sales|INKT - Operating Profitability|werewolftx.com (HOWL) - Operating Sales Margin|Immix (IMMX) - Operating Profitability|ALXO (ALX Oncology Holdings) - Operating Profitability|Operating Sales Margin CUE|PDS Biotechnology Corporation (PDSB) - Profitability of Operations|Operating Profitability Sonnet BioTherapeutics Holdings Inc. (SONN)|Operating Margin MAIA Biotechnology Inc (MAIA)|Operating Profitability Liminatus Pharma LIMN|Operating Profit Rate LVTX|NXTC: Operating Sales Margin|leaptx.com - Operating Profit Ratio|INTS: Operating Margin|Sensei Biotherapeutics Inc - Operating Profit Rate|Operating Sales Margin TOVX|Return on Sales by Operating Profit GRTS (Gritstone bio, Inc.)|Operating Sales Margin KA (kinetabio.com)|NEXI - Operating Return on Sales|Turnstone Biologics - Operating Sales Margin|Profitability of Operations Vaccinex Inc. (VCNX)|harpoontx.com - Operating Margin